Preclinical Study Design

Customized preclinical study design to select relevant in vivo models, endpoints and experimental strategies for robust drug development studies.

Preclinical study design overview

Successful preclinical studies require an experimental design aligned with the therapeutic candidate, biological question and development objectives. At IVRS, we combine scientific expertise with in vivo research experience to design tailored studies using relevant disease models, endpoints and read-outs, generating robust and decision-relevant data for preclinical drug development.

Our preclinical study design services

IVRS supports preclinical programs from initial study planning through model selection, endpoint definition and data collection strategies. Each study is tailored to the therapeutic candidate and development objectives to maximize scientific value while improving study efficiency.

Capabilities & read-outs

Study strategy & experimental design

Define study objectives, experimental groups, dosing strategies and timelines aligned with the drug development question.

Model selection

Select relevant in vivo disease models based on therapeutic targets, mechanisms and study objectives.

Endpoints & read-outs

Define meaningful biological endpoints and quantitative read-outs to generate robust, decision-relevant data.

Imaging-integrated study design

Integrate longitudinal in vivo imaging into study design to monitor biological changes over time and maximize information from each experiment.

Key capabilities

Let us help you to thrive

Do you want to learn more about our work and how we can help you?